期刊文献+

Access2免疫化学发光仪检测动物血清心肌钙蛋白I的分析性能确证 被引量:2

Analytical performance of ACCESS 2 immunoassay system in detecting Cardiac Troponin I in animals' serum
原文传递
导出
摘要 目的对美国贝克曼库尔特有限公司Access2免疫化学发光仪的主要分析性能进行验证。方法对该仪器检测项目血清心肌钙蛋白I(Cardiac Troponin I,c Tn I)进行性能验证。利用变异系数分别对质控及大鼠、犬和食蟹猴血清心肌钙蛋白I的精密度进行评估,并根据质控精密度数据对质控的靶值范围进行计算。利用相对偏差及靶值范围对准确度进行评价;利用携带污染率对携带污染情况进行评价。利用线性方程对Trop I的线性范围进行评价,同时对Access 2免疫化学发光仪检测动物血清c Tn I的功能灵敏度进行了评价。结果 Access2免疫化学发光仪检测c Tn I低、中、高3个水平质控的批内RSD均〈8%,批间RSD均〈63.75%,大鼠、犬和食蟹猴血清c Tn I批内RSD均〈8%。Bio-Rad 3水平质控的靶值范围分别为:0.363 8-0.473 5、1.898 6-2.819 3、7.950 3-9.367 6 ng/m L。Access2免疫化学发光仪检测c Tn I的RSD〈16.32%,且低、中、高3水平质控均在各自的靶值±30%范围内。携带污染率〈10%,线性验证高值动物血清按一定比例稀释后将所得理论值与实测值进行回归分析,a值介于0.95-1.05,R〉0.975,线性范围为0.016 0-82.843 3 ng/m L,功能灵敏度为0.007 6 ng/m L。结论 Access2免疫化学发光仪检测c Tn I的精密度、准确度、携带污染率及线性范围均在可接受范围内,且本研究获得了动物血清c Tn I检测的线性范围及功能灵敏度。因此,Access2免疫化学发光仪可用于临床前不同动物种属c Tn I的检测。 Objective To validate the main performance of Access 2 immunoassay system in detecting Cardiac Troponin I(c Tn I) in animals' serum from rats, dogs, and monkeys. Methods The precision was evaluated by coefficient of variance of within-run(RSDwithin %) and coefficient of variance of between-run(RSDtotal%). The target values range of BIO-RAD immunoassay plus control samples at three levels were calculated by precision data. The accuracy was assessed by Relative Bias(Bias%) and target values. Carryover circumstance was evaluated by carryover rates. Linear was evaluated by regression equation, and the functional sensitivity(FS) was established. Results The RSDwithin% of BIO-RAD immunoassay plus control samples at three levels were less than 8%, the RSDtotal% of BIO-RAD immunoassay plus control samples were less than 63.75%; The RSDwithin% of serum c Tn I from rats, dogs, and monkeys were less than 8%, respectively. The target value range of BIO-RAD immunoassay plus control samples at three levels were at 0.363 8—0.473 5 ng/m L, 1.898 6—2.819 3 ng/m L and 7.950 3—9.367 6 ng/m L, respectively. The Bias% of c Tn I was less than 16.32%, and the measured results were all within the respective target value range. The carryover rates of c Tn I was less than 10%. The equation of linearity range(0.016 0—82.843 3 ng/m L) of the theoretical value and detected value was got after serial dilution, in which a value was within the range 0.95—1.05(r 〉0.975). The FS was 0.007 6 ng/m L. Conclusion The precision, accuracy, carryover rates, and the linearity have a good performance, and FS of serum c Tn I from rats, dogs and monkeys were established. In conclusion, c Tn I could be detected via Access 2 immunoassay system in non-clinical studies.
出处 《药物评价研究》 CAS 2015年第2期180-184,共5页 Drug Evaluation Research
基金 国家"十二五"重大专项基金(2012ZX09505-001-003) 国家自然科学基金(81273603) 上海市青年科技启明星计划(14QB1400400)
关键词 心肌钙蛋白I 精密度 准确度 线性 功能灵敏度 动物血清 Cardiac Troponin I precision accuracy linearity functional sensitivity(FS) animals' serum
  • 相关文献

参考文献6

二级参考文献54

共引文献42

同被引文献23

  • 1Redfem W, Ewart L,Hammond T, et al. Impact and frequencyof different toxicities throughout the pharmaceutical lifecycle [J]. Toxicologist,2011,114 (S1): S1081.
  • 2Nilotinib. EMA Scientific Discussion [EB/OL]. (2007-11-05)[2015-07-08]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000798AVC500034398.pdf.
  • 3Sutent. FDA NDA Pharmacology Review [EB/OL].(2006-01-20) [2015-07-08]. http://www.accessdata.fda.gov/drugsatfda- docs/nda/2006/02193 8_S000_Sutent_PharmR.pdf.
  • 4SUTENTW (sunitinib malate). The FDA Approved Label [EB/OL]. (2011-05-20) [2015-07-08]. http://www.accessdata.fda.gov/drugsatfda docs/ label/2011 /021938sl3sl7s 181bl.pdf (orUnited States Product Information 2011).
  • 5VOTRIENTW. Data sheet of New Zealand “Medsafe”[EB/OL]. (2014-08-21) [2015-07-08]. http://www.medsafe.govt.nz/profs/datasheet/v/votrienttab .pdf.
  • 6Pegram M, Ngo D. Application and potential limitations ofanimal models utilized in the development of trastuzumab(Herceptin.): A case study [J]. Adv Drug Deliv Rev, 2006,58 (5-6): 723-734.
  • 7Wallace KB, Hausner E, Herman E,et al. Serum troponinsas biomarkers of drug-induced cardiac toxicity [J]. ToxicolPathol, 2004, 32(1): 106-121.
  • 8Daubert MA, Jeremias A. The utility of troponin measurementto detect myocardial infarction: review of the currentfindings [J]. Vase Health Risk Manag, 2010,6(1): 691-699.
  • 9Herman E, Zhang J, Knapton A, et al. Serum cardiac troponinT as a biomarker for acute myocardial injury induced by lowdoses of isoproterenol in rats[J]. Cardiovasc Toxicol, 2006,6(1):211-222.
  • 10Apple FS, Murakami MM, Ler R, et al. Characteristics ofcommercial cardiac Troponin I and T immunoassays in serumfrom rats, dogs, and monkeys with induced acute myocardialinjury [J]. Clin Chem,2008,54(12): 1982-1989.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部